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1. Introduction
Endobronchial brachytherapy alone or as part of a multi-
modal treatment, has a distinct role as palliative treatment in
advanced lung cancer and as a curative treatment in selected
cases of tumors conﬁned to the bronchial wall.
The safety and effectiveness of the procedure are opti-
mized by a multidisciplinary approach that includes an
expert bronchoscopist, a radiation oncologist and a radiation
physicist, supported by a dedicated nurse and radiotherapy
technician.
Next we describe the methodology used in our center,
where we have the experience of 7 years in treating 37 tumors
in 31 patients. In 20 cases (64.5%), they had curative intent
and 11 (35.5%) palliative intent. On 14 occasions, prior External
Beam Radiation Therapy was used and in 7 cases was asso-
ciated with other debulking methods. Overall, after a month
of treatment, there was clinical improvement in 73.7% and
endoscopic improvement in 87%. The complete response of
the treated area for curative treatments was 70% at 1 month
and 66.7% at 1 year. There were serious complications in 9.7%
of cases.
2. Material resources required
A Videobronchoscopy tower with the ability to record images
and videos. A therapeutic ﬂexible bronchoscopes with awork-
ing channel of at least 2mm. Suction system, Oxygen delivery
system, and Fluoroscopy equipment. A polyethylene Catheter
applicator 5 or 6 Fr. A simulation “dummy”wire.ACT for Image
Acquisition, a computer assisted 3D dosimetric Planner and a
192Ir remote after loading unit.
3. The procedure
The candidate cases are discussed for treatment in the
Brachytherapy Committee.
Once the case is accepted, we update if necessary, CT
images and bronchoscopy to assess speciﬁcally the exact size
and location of the tumor, degree of bronchial obstruction,
lesion length, permeability and viability of distal airway or
need of other debulking methods.
On the day of treatment, the patient is prepared as for a
ﬂexible bronchoscope, fasting of at least 4h, a permeable intra-
venous access and supplemental oxygen administered by a
modiﬁed venturi mask. We proceed to EKG, blood pressure
and pulse oximetry monitoring. Then, the patient is placed in
supine position in a specially designed operating table, which
allows transport without mobilize.
We used bronchoscopist administered conscious sedation,
using IV midazolam and fentanyl, lidocaine topical anes-
thesia for the nasal passages and pharynx and cricothyroid
puncture for the vocal cords. The ﬂexible bronchoscope is
inserted preferably using a transnasal approach (which will
facilitate the subsequent anchoring); if not possible, can be
inserted through the mouth, through endotracheal tube and
even through a tracheostomy stoma.
The distal end of the catheter is placed at the site of the
endobronchial tumor and it should be at least 1 cm beyond
the distal end of the lesion, and anchored if possible into a seg-
mental bronchus for minimizing any displacement. In case of
bronchial stump, it requires great experiencewith the catheter
stiffness, elasticity and torque for optimal placement in close
contact with the lesion.
The bronchoscope is then withdrawn, leaving the catheter
in situ with the aid of ﬂuoroscopy and a scalated dummy
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seed probe is placed to simulate the pathway of the radi-
ation source. The proximal catheter anchoring to the nose,
mouth, endotracheal tube or tracheostomy, is performed with
adhesive strips, and a new bronchoscopy to check the proper
placement is performed if necessary.
A second and third catheter may be placed in similar fash-
ion if necessary, to optimize the dose distribution in tumors
affecting carinae or in cases of multiple tumors.
Next, the patient is moved to the radiology area, for a chest
CT image acquisition that includes the area of the lesion with
wide margins.
The images are sent via intranet to the virtual simulation
console, where the radiotherapy oncologist with the assis-
tance of the bronchoscopist, proceeds to deﬁne the volume
to be treated and adjacent critical organs if any (esophagus,
great vessels, etc.).
The target volume is newly transferred from the virtual
simulation console to the 3D planner, where the radiation
oncologist, with the assistance of the radiation physicist, sets
the most appropriate treatment plan.
Meanwhile, the patient is transferred back to the treatment
area. The control of cough is achieved using fentanyl. If nec-
essary, new radiological control is performed to check that it
has not moved the catheter, in which case there would have
to repeat the whole of process.
The treatment takes place in a shielded room. After
removal the dummy seed wire, the catheter is connected
to the 192Ir remote after loading unit, and the source is
moved through the applicator to the programmed locations,
controlled from a computer, using a motor driving sys-
tem, with the patient constantly controlled by a closed TV
circuit.
After ﬁnished the treatment, the catheter is removed, and
the patient is kept under observation for 2h, until discharge.
During this time the pulmonologist controls and eventually
attends any acute complications related to the procedure
(bronchospasm, pneumothorax, arrhythmia . . .).
Unless complications or patient status forbid, the treat-
ments are performed on an outpatient basis with weekly
fractions until the total dose is complete.
Once completed the whole treatment (between 2 and
6 fractions), both clinical and bronchoscopic controls are per-
formed, after 1 month on palliative treatment, and at 3, 6
and 12 months in case of curative one, in order to deter-
mine the degree of response and possible occurrence of late
complications.
